ILC Dover advances media and buffer prep powder handling by offering robust DoverPac® SF customized to meet Biopharmaceutical needs

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) July 29, 2010 -- ILC Dover announced today that their DoverPac® SF family is advancing the state-of-the-art in buffer/media preparation for the biopharmaceutical industry with these single use, flexible systems.

By using ILC’s durable ArmorFlex® materials, 3D disposable vessels have been created which ease powder transfer while assuring a robust construction. Drop testing employed during the system development served the company well when a biopharmaceutical customer conducted side by side comparisons against the competition at a recent Factory Acceptance Test (FAT). ILC’s DoverPac® SF was able to withstand the most severe test regime while other systems did not.

Our extensive materials and design knowledge gained through decades of collaboration with government and commercial customers helps us create robust seams and 3D constructions for the most critical applications”, said Alan George, ILC Dover’s Pharmaceutical Product Line Manager. “Design analysis and customer feedback helped us develop the DoverPac® SF with blended, structural seams that minimize powder retention and speed transfer operations.”

The company offers the product in a range of standard sizes and sanitary flange interfaces and also customizes designs to meet specific customer applications. Models are available with and without external restraints.

About ILC Dover

Since 1947, ILC has been active in the design and development of products for both government and industry. Whether protecting personnel in hostile environments, containing pharmaceuticals, or developing unique inflatable devices, ILC has an enviable record of performance. Our Department of Defense, commercial, and NASA customers rely on ILC Dover’s multi-disciplined technical expertise to provide innovative softgoods solutions for a wide range of applications.
Man landed on the moon – we created the spacesuit.

Researchers develop wonder drugs – we aid in safe production.
Rovers explore Mars – we help them land safely.
ILC Dover – creating what’s next
# # #

Media Contact:
ILC Dover
Stephanie Arthurs
e-mail: arthus@ilcdover.com

biopharmaceutical     DoverPac     ILC Dover